Sawai Receives Approval for Tadalafil Tablets
2020-02-20 · Upsher-Smith Laboratories · original upsher-smith.com ↗
Osaka, Japan – February 19, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approval by the Ministry of Health, Labour and Welfare (MHLW) for Tadalafil tablets (the branded product: Cialis®). Tadalafil tablets are prescribed for the treatment of erectile dysfunction. The products approved by MHLW on Feb. 19. Product Name: TADALAFIL Tablets 10 mg CI [SAWAI], 20 mg CI [SAWAI] Generic name: Tadalafil Brand products: Cialis® Tablets 10 mg, 20 mg The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States. PR / IR Group, Corporate Strategy Department, Sawai Pharmaceutical Co., Ltd. E-mail: [email protected]
The release as fetched from its publisher. upsher-smith.com ↗